Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Innovation in the biopharmaceutical sector is driven by access to critical, high-quality chemical intermediates. Among these, UDP-Rhamnose (CAS 1955-26-6) has emerged as a compound of significant importance, particularly in areas like glycoprotein engineering and vaccine development. NINGBO INNO PHARMCHEM CO.,LTD., a leading manufacturer and supplier based in China, is at the forefront of providing this essential biochemical reagent to the global scientific community.
UDP-Rhamnose is a metabolically activated form of L-rhamnose, a deoxy sugar that plays a role in various biological processes, including the synthesis of bacterial cell walls and plant glycans. Its primary function in biopharmaceutical research is as a substrate for glycosyltransferases, enabling the precise incorporation of L-rhamnose into protein structures or polysaccharide antigens. This capability is invaluable for scientists aiming to develop therapeutic proteins with modified pharmacokinetic profiles or to create synthetic vaccine components.
The development of advanced biologics often requires sophisticated manipulation of protein glycosylation. By using UDP-Rhamnose, researchers can precisely control the addition of L-rhamnose residues, influencing factors such as protein stability, solubility, and immunogenicity. This level of control is crucial for optimizing the performance of therapeutic proteins, such as antibodies and enzymes. Companies looking to buy high-purity UDP-Rhamnose for these demanding applications recognize the importance of a reliable supplier. NINGBO INNO PHARMCHEM CO.,LTD. offers a consistent supply of this critical intermediate from our manufacturing facilities in China.
In the field of vaccine development, UDP-Rhamnose is particularly relevant for the synthesis of O-antigens, which are crucial for the immunogenicity of many bacterial vaccines. The precise enzymatic synthesis of these complex structures, often involving L-rhamnose units, relies on the availability of pure UDP-Rhamnose. This has significant implications for creating more effective and targeted vaccines against a range of bacterial infections. As the demand for such specialized materials grows, manufacturers like us are essential partners in advancing global health.
For biopharmaceutical innovators seeking to leverage the potential of UDP-Rhamnose, choosing the right supplier is key. NINGBO INNO PHARMCHEM CO.,LTD. provides high-purity UDP-Rhamnose (CAS 1955-26-6), manufactured to rigorous standards, ensuring reliability for your critical research and development projects. We invite you to contact us for a quotation and to discuss how we can support your innovative work. Partner with a leading Chinese manufacturer to secure your supply of this vital biochemical intermediate.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
